ERBB2 and breast carcinoma: In node-positive patients, TNBC breast carcinoma tended to demonstrate the worst 5-year overall survival by log-rank analysis (Figure 3B), and ER-positive and/or PgR-positive and HER2-negative patients had the best 5-year overall survival (p < 0.0001).